Publication | Closed Access

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

Non-small-cell Lung CancerMedicinePathologyBronchial NeoplasmMolecular OncologyPretreated Egfr Thr790met-positiveCancer TreatmentOncologyRadiation OncologyCancer ResearchLung CancerTumor Biology